SIRT Versus cTACE for Unresectable HCC (CHANCE2506)

Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma

NCT01833299 ·Status: COMPLETED ·Phase: PHASE3

Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma

NCT06896396 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

NCT02807181 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

NCT00503867 ·Status: TERMINATED ·Phase: NA

Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)

NCT01135056 ·Status: UNKNOWN ·Phase: PHASE3

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

NCT06365034 ·Status: RECRUITING

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

NCT06712017 ·Status: ENROLLING_BY_INVITATION

TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma

NCT02529761 ·Status: UNKNOWN ·Phase: NA

Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence

NCT04213118 ·Status: UNKNOWN ·Phase: PHASE2

Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT06540508 ·Status: ENROLLING_BY_INVITATION

TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer

NCT02794337 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma

NCT02513199 ·Status: COMPLETED ·Phase: PHASE2

Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma

NCT06788353 ·Status: RECRUITING

TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma

NCT01869088 ·Status: UNKNOWN ·Phase: PHASE3

A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

NCT05320692 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Treatment for Bile Duct Cancer in the Liver

NCT02167711 ·Status: COMPLETED ·Phase: PHASE2

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

NCT04592029 ·Status: UNKNOWN ·Phase: PHASE1

TACE Combined With Sorafenib and Tislelizumab for Advanced HCC

NCT04599777 ·Status: COMPLETED ·Phase: PHASE2

TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma

NCT04559607 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma

NCT00652587 ·Status: COMPLETED ·Phase: PHASE3

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

NCT07206511 ·Status: NOT_YET_RECRUITING

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

NCT05377034 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)

NCT03851887 ·Status: UNKNOWN ·Phase: PHASE2

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

NCT01004978 ·Status: COMPLETED ·Phase: PHASE3

TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma

NCT04103398 ·Status: COMPLETED ·Phase: PHASE3